AiCure

@PharmaVoice released their 2023 Year in Preview. In the article, @AiCure CEO Edward Ikeguchi said, “The most meaningful innovations will be those that get at the heart of patients’ experiences during a clinical trial.” Read the full article :info.aicure.com/2023-PharmaVoi… #tech

@AiCure CEO Edward Ikeguchi shares his insights in @PharmaVoice's new article. Read what he has to say about decentralized clinical trials: info.aicure.com/healthare-tech… #healthcaretech #decentralizedclinicaltrials

Applied Clinical Trials Magazine recently published "How a Global Privacy Standard Can Boost Patient Trust," an article written by @AiCure's General Counsel & Chief Administrative Officer Gordon Kessler. Read the Article Here: info.aicure.com/how-a-global-p… #dataprivacylaw

@AiCure Platform allows commercial organizations to explore, understand and operationalize data by leveraging digital biomarkers and predictive analytics. Read the fact sheet and learn more: info.aicure.com/Platform-Comme… #digitalbiomarkers #predictiveanalytics

@AiCure's most recent poster showcased a study where digital biomarkers tracked the speech patterns of participants reading a passage out loud. The study explored the feasibility of using digital biomarkers to confirm informed consent. Get the poster: info.aicure.com/Digital-Biomar…

Alzheimer's disease (AD) affects over 6 million worldwide. A majority of AD diagnoses occur in the penultimate & final stages of the disease's progression. Read our fact sheet & learn more about how @AiCure is enhancing Alzheimer's research: info.aicure.com/Alzheimers-Fac… #Alzheimers

In @AiCure's latest blog post Matthew Harrington discusses how Parkinson's Patient Advocate @CathyMolohan views the impact of digital biomarkers and their potential to advance Parkinson's research. info.aicure.com/Parkinsons-Pat… #Parkinsons #digitalbiomarkers

@pfizer recently announced @AiCure as the winner of their Clinical Study Adherence Open Innovation Challenge where they looked for innovative and patient-friendly solutions to keep patients engaged throughout clinical trials. breakthroughchangeaccelerator.com/clinical-study… #medicationadherence

#Digitalbiomarkers (DBM) can consistently and objectively quantify a patient’s disease state & response to treatment. @AiCure is working to democratize access to DBM algorithms so researchers can use them. Learn about the OpenDBM open-source community: info.aicure.com/OpenDBM-Websit…

AiCure software helps clinical trial participants with trial protocols and medication adherence. It also gives drug sponsors and clinical trial sites deeper understanding of treatment effects. Learn more by visiting our solutions page: info.aicure.com/AiCure-Solutio… #drugdevelopment

@AiCure's CFO Brian Jung has been named as one of California's top chief financial officers in the medical space by CFO (Boardroom Media). See the full list: cfo.br.media/meet-californi… #leadership #CFO

In AiCure's latest blog post General Council & CAO Gordon Kessler discusses how improved global privacy legislation will result in greater levels of trust from clinical trial participants. Read the Full Blog: info.aicure.com/How-Achieving-… #dataprivacylaw #clinicaltrials

From clinical trial enrollment through completion, understanding medication adherence is critical to data integrity and @AiCure offers a competitive edge where traditional methods fall short. Read the full blog to learn more: info.aicure.com/Medication-Adh… #clinicaltrial #adherence

Clinical trials often suffer from unplanned loss of statistical power due to low medication adherence. @AiCure's blog highlights the lessons learned in the webinar "Leveraging Predictive Dosing to Reduce Clinical Trial Risk." Read More: info.aicure.com/Understanding-… #clinicaltrials

@AiCure's new Clinical Site Services program provides sites with end-to-end, customized support and monitoring of metrics related to adherence, compliance, data management, and technology use among study participants. info.aicure.com/AiCure-Launche… #clinicaltrials

@AiCure is proud to announce our Chief Medical Officer Rich Christie MD, PhD has been named as one of the @PharmaVoice 100 most inspiring leaders in the life-science industry. Read about his contributions here: pharmavoice.com/news/rich-chri… #leadership #trailblazer

@PharmExec quoted @AiCure's Chief Medical Officer Rich Christie MD, PhD as he discusses how digital biomarkers can be used to spot warning signs and symptoms of disease. Read the article: info.aicure.com/Assessing-Adva… #personalizedmedicine #digitalbiomarkers

@AiCure's Digital Biomarker solution remotely detects subtle changes in treatment response through audio and visual data capture, elevating trial data integrity and optimizing patient outcomes. Learn More: info.aicure.com/AiCure-Digital… #PatientCare

Pharmaceutical Executive Magazine quoted AiCure Chief Medical Officer Rich Christie MD, PhD regarding how AI is used to fully understand the patient experience as well as predict which patients will or will not follow their treatment regimen. info.aicure.com/AI-Opens-Door-… #AI

@AiCure Patient Connect is a smartphone-based application leveraging computer vision and AI to remotely assess patient dosing behavior, ensure treatment compliance and activate interactive support. Learn how to enhance participant adherence: info.aicure.com/l/765923/2022-…